Eton Pharmaceuticals (ETON) Accumulated Expenses: 2019-2025
Historic Accumulated Expenses for Eton Pharmaceuticals (ETON) over the last 7 years, with Sep 2025 value amounting to $9.1 million.
- Eton Pharmaceuticals' Accumulated Expenses rose 18893.75% to $9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.1 million, marking a year-over-year increase of 18893.75%. This contributed to the annual value of $8.9 million for FY2024, which is 65.50% up from last year.
- Latest data reveals that Eton Pharmaceuticals reported Accumulated Expenses of $9.1 million as of Q3 2025, which was up 22.23% from $7.5 million recorded in Q2 2025.
- In the past 5 years, Eton Pharmaceuticals' Accumulated Expenses registered a high of $11.4 million during Q2 2024, and its lowest value of $48,000 during Q3 2024.
- Its 3-year average for Accumulated Expenses is $6.9 million, with a median of $7.5 million in 2025.
- As far as peak fluctuations go, Eton Pharmaceuticals' Accumulated Expenses slumped by 99.33% in 2024, and later soared by 18,893.75% in 2025.
- Eton Pharmaceuticals' Accumulated Expenses (Quarterly) stood at $1.4 million in 2021, then surged by 168.08% to $3.7 million in 2022, then skyrocketed by 47.08% to $5.4 million in 2023, then surged by 65.50% to $8.9 million in 2024, then spiked by 18,893.75% to $9.1 million in 2025.
- Its Accumulated Expenses was $9.1 million in Q3 2025, compared to $7.5 million in Q2 2025 and $7.5 million in Q1 2025.